in Health care
Piramal Pharma Digwal facility successfully concludes USFDA inspection
Mumbai: Piramal Pharma Limited has recently announced that the US Food and Drug Administration (USFDA) has successfully completed the Good Manufacturing Practices (GMP) inspection with Zero Form – 483 observations at the company’s Digwal facility. An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed […] More
